Transcriptomic analysis of ∼400 NSCLC patients treated with ICBT corroborated that high IFN-γ activity correlated with response, and, moreover, that the IFN-γ-induced immunoproteasome was essential [38]. The gene discussed is IFNG; the disease is non-small cell lung carcinoma.